These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4292852)

  • 21. Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions.
    Fuchsberger N; Hajnická V; Boreckyý L
    Acta Virol; 1975 Jan; 19(1):59-66. PubMed ID: 235199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of blood clearance rates on interferon production and virulence of Mengo virus plaque mutants in mice.
    Campbell JB; Buera JG; Tobias FM
    Can J Microbiol; 1970 Sep; 16(9):821-6. PubMed ID: 4319089
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of Mengo virus by interferon.
    Gauntt CJ; Lockart RZ
    J Bacteriol; 1966 Jan; 91(1):176-82. PubMed ID: 4285530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stimulation by isoprinosine of the antiviral effect of interferon].
    Chany C; Cerutti I
    C R Acad Hebd Seances Acad Sci D; 1977 Feb; 284(6):499-501. PubMed ID: 66996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the efficacy of endogenous, exogenous, and combined endogenous-exogenous interferon in the treatment of mice infected with encephalomyocarditis virus.
    Gresser I; Fontaine-Brouty-Boyé D; Bourali C; Thomas MT
    Proc Soc Exp Biol Med; 1969 Jan; 130(1):236-42. PubMed ID: 4302959
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon.
    Ankel H; Mittnacht S; Jacobsen H
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2355-64. PubMed ID: 2414395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human interferon suppression of retrovirus production and cell fusion, and failure to inhibit replication of encephalomyocarditis virus in rhabdomyosarcoma (RD114) cells.
    Tomita Y; Nishimaki J; Takahashi F; Kuwata T
    Virology; 1982 Jul; 120(1):258-63. PubMed ID: 6179291
    [No Abstract]   [Full Text] [Related]  

  • 28. Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon.
    Haase AT; Levy H; Baron S; Kasel JA
    J Virol; 1969 Oct; 4(4):490-5. PubMed ID: 4309883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of interferon activity in mouse serum by phase I Coxiella burneti antigen.
    Brezina R; Kazár J; Schramek S
    Acta Virol; 1968 Jul; 12(4):382. PubMed ID: 4386026
    [No Abstract]   [Full Text] [Related]  

  • 30. Relation of incubation temperature to interferon production in mouse peritoneal cells infected with Newcastle disease virus.
    Waschke K; Lackovic V; Borecký L
    Acta Virol; 1969 Sep; 13(5):387-92. PubMed ID: 4398703
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of incomplete viruses and interferon in persistent infection of mouse cells with Sindbis virus.
    Inglot AD; Chudzio T; Albin M
    Acta Microbiol Pol A; 1973; 5(3):181-2. PubMed ID: 4358717
    [No Abstract]   [Full Text] [Related]  

  • 32. The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro.
    Lackovic V; Borecký L; Sikl D; Masler L; Bauer S
    Acta Virol; 1967 Nov; 11(6):500-5. PubMed ID: 4383884
    [No Abstract]   [Full Text] [Related]  

  • 33. Emulsifiers that enhance susceptibility to virus infection: increased virus penetration and reduced interferon response.
    Lee SH; Laltoo M; Crocker JF; Rozee KR
    Appl Environ Microbiol; 1980 Oct; 40(4):787-93. PubMed ID: 6158915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of interferon in tick-borne encephalitis virus-infected L cells. IV. Origin of insusceptibility of persistently infected L cells to the action of exogenous interferon.
    Stancek D
    Acta Virol; 1965 Sep; 9(5):409-15. PubMed ID: 4379466
    [No Abstract]   [Full Text] [Related]  

  • 35. [Potentiation of the antiviral activity of human interferons by virazole in in vitro experiments].
    Meshkova EN; Mentkevich LM
    Vopr Virusol; 1987; 32(5):570-3. PubMed ID: 2448957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluorescence serology studies on the effects of antiviral agents on virus replication. I. The action of beta-2-DL-thienyl alanine on the replication of Mengo virus].
    Wagner M; Veckenstedt A
    Arch Gesamte Virusforsch; 1969; 28(2):101-15. PubMed ID: 4313030
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of immunosuppressive drugs on replication of Col MM virus and productive of interferon in vivo.
    Golubska B; Szalaty H
    Arch Immunol Ther Exp (Warsz); 1974; 22(4):445-56. PubMed ID: 4371712
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of the chain length of oligonucleotides on interferon induction].
    Wacker A; Singh A; Svec J; Lodemann E
    Naturwissenschaften; 1969 Dec; 56(12):638. PubMed ID: 4316113
    [No Abstract]   [Full Text] [Related]  

  • 39. [Induction of interferon synthesis by double-stranded RNA. I. Application to the study of the multiplication cycle of Mengo virus].
    Falcoff R; Falcoff ET
    Biochim Biophys Acta; 1969 Jun; 182(2):501-10. PubMed ID: 4307590
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferon-inducing capacity of double-stranded RNA. II. Studies on Mengo virus replicatative intermediate].
    Falcoff R; Falcoff E
    Biochim Biophys Acta; 1970 Jan; 199(1):147-58. PubMed ID: 4312964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.